OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Kunxian capsule alleviates renal damage by inhibiting the JAK1/STAT1 pathway in lupus nephritis
Chen Cheng, Rongrong Zhu, Mingjian Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 310, pp. 116349-116349
Closed Access | Times Cited: 9
Chen Cheng, Rongrong Zhu, Mingjian Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 310, pp. 116349-116349
Closed Access | Times Cited: 9
Showing 9 citing articles:
Clinical study, network pharmacology, and molecular docking of Kunxian capsule in treating idiopathic membranous nephropathy
Jia Lv, Xinyu Gao, Lihua Liu, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Jia Lv, Xinyu Gao, Lihua Liu, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Efficacy and safety of Kunxian in IgA nephropathy
Yang Yang, Xiang Li, Honghong Zou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yang Yang, Xiang Li, Honghong Zou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
LATS2 degradation promoted fibrosis damage and rescued by vitamin K3 in lupus nephritis
Chen Cheng, Hao Yang, Chan Yang, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 3
Chen Cheng, Hao Yang, Chan Yang, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 3
Cordyceps protein alleviates renal injury by inhibiting T cell infiltration and Th1 cell differentiation in lupus nephritis mice
Zhengyue Liao, Xingmao Yang, Liying He, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112566-112566
Closed Access | Times Cited: 2
Zhengyue Liao, Xingmao Yang, Liying He, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112566-112566
Closed Access | Times Cited: 2
Screening of key functional components of Taohong Siwu Decoction on ischemic stroke treatment based on multiobjective optimization approach and experimental validation
Anqi Xu, Wenxing Li, Jieqi Cai, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Anqi Xu, Wenxing Li, Jieqi Cai, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Network pharmacology prediction, molecular docking, and molecular dynamics simulation-based strategy to explore the potential mechanism of Huashanshen dripping pill against asthma
Xiaoyu Wang, Yansu Ji, Xin Jin, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 10, pp. 1362-1378
Closed Access | Times Cited: 1
Xiaoyu Wang, Yansu Ji, Xin Jin, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 10, pp. 1362-1378
Closed Access | Times Cited: 1
LncRNA XIST/miR-381-3P/STAT1 axis as a potential biomarker for lupus nephritis
J.-L. Chen, Ming Li, Shuangshuang Shang, et al.
Lupus (2024) Vol. 33, Iss. 11, pp. 1176-1191
Closed Access | Times Cited: 1
J.-L. Chen, Ming Li, Shuangshuang Shang, et al.
Lupus (2024) Vol. 33, Iss. 11, pp. 1176-1191
Closed Access | Times Cited: 1
STAT1 aggravates kidney injury by NOD-like receptor (NLRP3) signaling in MRL-lpr mice
Changzhi Zheng, Fangfang Shang, Run Cheng, et al.
Journal of Molecular Histology (2024) Vol. 55, Iss. 4, pp. 555-566
Closed Access
Changzhi Zheng, Fangfang Shang, Run Cheng, et al.
Journal of Molecular Histology (2024) Vol. 55, Iss. 4, pp. 555-566
Closed Access
Identification of novel biomarkers for lupus nephritis
Zhengyue Liao, Liying He, Jiaojiao Fu, et al.
Biomolecules and Biomedicine (2024)
Open Access
Zhengyue Liao, Liying He, Jiaojiao Fu, et al.
Biomolecules and Biomedicine (2024)
Open Access
